Paysign Inc (PAYS) Stock Price, Quote & News

Company Profile

Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit ac...

Industry: Software - Infrastructure

Sector: Technology

Phone: 702 453 2221

Website: www.paysign.com

Address:

2615 St. Rose Parkway, Henderson, United States

Guacomole Apr. 2 at 1:30 PM

$PAYS How long before we retest $8?

1 · Reply

ChartingMasters Mar. 30 at 8:22 AM

$CLSK $GLXY $U $PAYS )(

0 · Reply

OwlKing Mar. 29 at 7:36 PM

$PAYS ;)-

0 · Reply

Jpike55 Mar. 29 at 3:19 PM

$PAYS Solid company getting some love and potential buy out? Solid connections to big pharma!

2 · Reply

MikiTrader Mar. 29 at 1:09 PM

$PAYS It looked ready to move. Not some huge home run play, but still a pretty solid company. Kind of like an RMD-style name. I just can’t figure out what management is thinking.

2 · Reply

TradeWithCreed Mar. 27 at 7:55 PM

Looks like ticker FGI is the next micro float ticker to make a big move ! Every small float ticker has been running like crazy recently FGI starting to make its move now! Only 580k shares outstanding! 💎 Accumulating: $RBNE $SATL $PAYS $KOD FG

0 · Reply

BuyOnRedSellOnGreen Mar. 27 at 2:20 PM

$PAYS

0 · Reply

NolanMerrick19 Mar. 27 at 9:17 AM

$PAYS under the radar mover with squeeze risk if bids keep stepping up

1 · Reply

historyperson Mar. 26 at 7:09 PM

$PAYS Total Addressable Market (TAM) During the latest call, the executive team outlined a massive runway for the Patient Affordability segment: Immediate TAM: $500 million to $850 million annually within the current scope of copay assistance. Growth Opportunity: Currently, Paysign only has about 4% to 7% of this market. The GLP-1 Factor: Management explicitly mentioned they are working to enter the GLP-1 (weight loss/diabetes) market within the next 12–18 months. Capturing just one or two major weight-loss drug programs could potentially double their current program count overnight.

0 · Reply

historyperson Mar. 26 at 5:53 PM

$PAYS 2026 guidance calls for 92% net income growth LOL. $8/share will be cheap.

1 · Reply

Paysign Is On A Roll

Mar 25, 2026, 5:04 AM EDT - 10 days ago

Paysign, Inc. (PAYS) Q4 2025 Earnings Call Transcript

Mar 24, 2026, 4:10 PM EDT - 11 days ago

Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

Feb 24, 2026, 4:30 PM EST - 5 weeks ago

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

Jan 21, 2026, 4:30 PM EST - 2 months ago

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

Jan 7, 2026, 8:05 AM EST - 3 months ago

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

Nov 13, 2025, 4:30 PM EST - 5 months ago

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

Nov 12, 2025, 7:21 PM EST - 5 months ago

Paysign, Inc. (PAYS) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 4:05 PM EST - 5 months ago

Paysign, Inc. Reports Third Quarter 2025 Financial Results

Oct 14, 2025, 4:15 PM EDT - 6 months ago

Paysign to Host Third Quarter 2025 Earnings Call

Oct 1, 2025, 7:04 AM EDT - 6 months ago

Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)

Sep 22, 2025, 8:05 AM EDT - 6 months ago

Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

Sep 15, 2025, 7:20 PM EDT - 7 months ago

Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Sep 15, 2025, 8:05 AM EDT - 7 months ago

Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business

Sep 3, 2025, 4:30 PM EDT - 7 months ago

Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference

Aug 14, 2025, 8:30 AM EDT - 8 months ago

Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board

Aug 8, 2025, 10:00 AM EDT - 8 months ago

Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference

Aug 5, 2025, 10:44 PM EDT - 8 months ago

Paysign, Inc. (PAYS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:05 PM EDT - 8 months ago

Paysign, Inc. Reports Second Quarter 2025 Financial Results

Jul 12, 2025, 6:45 AM EDT - 9 months ago

Paysign: Growth In Payments Met With High Valuation

Jul 8, 2025, 4:30 PM EDT - 9 months ago

Paysign to Host Second Quarter 2025 Earnings Call

Jun 11, 2025, 7:00 AM EDT - 10 months ago

Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers

Jun 5, 2025, 7:00 AM EDT - 10 months ago

Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition

May 29, 2025, 4:30 PM EDT - 11 months ago

Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference

May 9, 2025, 11:33 AM EDT - 11 months ago

PaySign Analysts Increase Their Forecasts After Better-Than-Expected Earnings

May 8, 2025, 10:29 PM EDT - 11 months ago

Paysign, Inc. (PAYS) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 11 months ago

Paysign, Inc. Reports First Quarter 2025 Financial Results

Apr 22, 2025, 4:30 PM EDT - 1 year ago

Paysign to Host First Quarter 2025 Earnings Call

Apr 9, 2025, 4:15 PM EDT - 1 year ago

Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25

Mar 25, 2025, 6:27 PM EDT - 1 year ago

Paysign, Inc. (PAYS) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 4:03 PM EDT - 1 year ago

Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

Feb 27, 2025, 4:30 PM EST - 1 year ago

Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call

Feb 19, 2025, 3:05 AM EST - 1 year ago

Paysign: Shifting Revenue Mix, Falling Stock, Compelling Opportunity

Feb 4, 2025, 8:05 AM EST - 1 year ago

Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions

Nov 20, 2024, 5:29 AM EST - 1 year ago

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 5, 2024, 9:02 PM EST - 1 year ago

Paysign, Inc. (PAYS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 4:02 PM EST - 1 year ago

Paysign, Inc. Reports Third Quarter 2024 Financial Results

Oct 15, 2024, 4:30 PM EDT - 1 year ago

Paysign to Host Third Quarter 2024 Earnings Call

Aug 19, 2024, 4:52 PM EDT - 1 year ago

Paysign: The Return Of The King Of Medical Fintech

Aug 8, 2024, 4:15 PM EDT - 1 year ago

Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference

Jul 31, 2024, 8:43 PM EDT - 1 year ago

Paysign, Inc. (PAYS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:02 PM EDT - 1 year ago

Paysign, Inc. Reports Second Quarter 2024 Financial Results

Jul 9, 2024, 4:30 PM EDT - 1 year ago

Paysign to Host Second Quarter 2024 Earnings Call

Jun 20, 2024, 4:30 PM EDT - 1 year ago

Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25

Jun 18, 2024, 4:30 PM EDT - 1 year ago

Paysign, Inc. to Participate in the 2024 iAccess Alpha Buyside Best Ideas Summer Conference

Jun 6, 2024, 4:30 PM EDT - 1 year ago

Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference

May 11, 2024, 5:30 PM EDT - 2 years ago

Paysign, Inc. (PAYS) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:10 PM EDT - 2 years ago

Paysign, Inc. Reports First Quarter 2024 Financial Results

Apr 9, 2024, 4:30 PM EDT - 2 years ago

Paysign to Host First Quarter 2024 Earnings Call

Guacomole Apr. 2 at 1:30 PM

$PAYS How long before we retest $8?

1 · Reply

ChartingMasters Mar. 30 at 8:22 AM

$CLSK $GLXY $U $PAYS )(

0 · Reply

OwlKing Mar. 29 at 7:36 PM

$PAYS ;)-

0 · Reply

Jpike55 Mar. 29 at 3:19 PM

$PAYS Solid company getting some love and potential buy out? Solid connections to big pharma!

2 · Reply

MikiTrader Mar. 29 at 1:09 PM

$PAYS It looked ready to move. Not some huge home run play, but still a pretty solid company. Kind of like an RMD-style name. I just can’t figure out what management is thinking.

2 · Reply

TradeWithCreed Mar. 27 at 7:55 PM

0 · Reply

BuyOnRedSellOnGreen Mar. 27 at 2:20 PM

$PAYS

0 · Reply

NolanMerrick19 Mar. 27 at 9:17 AM

$PAYS under the radar mover with squeeze risk if bids keep stepping up

1 · Reply

historyperson Mar. 26 at 7:09 PM

0 · Reply

historyperson Mar. 26 at 5:53 PM

$PAYS 2026 guidance calls for 92% net income growth LOL. $8/share will be cheap.

1 · Reply

cbixler Mar. 26 at 4:08 PM

$PAYS 200 day MA test this morning. Not ready to break it. $5.09 was a pretty strong line of support in 2nd half of 2025. Let’s see if we hold above that.

1 · Reply